Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study
Belén Alejos, Dácil García, Luis Miguel Garcia Sousa, Íñigo Sagastagoitia(Hospital Clínico San Carlos), Rafael Rubio(Research Institute Hospital 12 de Octubre), Francesc Vidal(Institut de Recerca Biomèdica Catalunya Sud), Ana López Lirola, Féderico García, Juan Berenguer(Instituto de Salud Carlos III), Antonio Rivero(University of Southern California), Inmaculada Jarrín(Instituto de Salud Carlos III), Livia Giner, Joaquín Portilla(Hospital General Universitario de Alicante Doctor Balmis), Diego Torrús, Carlos Iniesta, Irene Portilla, María Ángeles Muñoz‐Fernández(Instituto de Salud Carlos III), Marta Rava(Instituto de Salud Carlos III), Azucena Bautista(Hospital Universitario de La Princesa), Vicente Boix, Cristina Moreno(Universidad de Alcalá), José Antonio Iribarren(Biogipuzkoa Health Research Institute), Gema García, María Luisa Navarro, Juan González, Marcos Díez, Félix Gutiérrez(Universitat de Miguel Hernández d'Elx), L. Gimeno, Inés Suárez‐García(Centro de Investigación Biomédica en Red)
Cited by 9
Related Papers
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
|Clinical Microbiology and Infection|2020|423